Cirrus Adds Clinical-Scale Manufacturing

SourceNorth Carolina Biotechnology Center
Date Published11/03/2014
Author NameJim Shamp
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Cirrus Pharmaceuticals
Parent companyKemwell Biopharma
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Transplant
Total number of jobs (added or to be added):4
Year reshoring announced:2014
Year reshoring implemented or to be implemented:2014
Domestically, the work will be done:In-house
Country(ies) from which reshored:India
City reshored to:Morrisville
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredClinical Scale Pharmaceuticals
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Manufacturing/engineering joint innovation (R&D), Re-design of the part, Other, Proximity to Market
Find Reshoring Articles